1 / 6

China Interventional Cardiovascular Device Industry 2017

At present, half of the Chinese interventional cardiovascular device industry is dominated by domestic companies led by MicroPort, Lepu Medical, Lifetech Scientific, and Dalian Yinyi. In 2013, 53.4% of the Chinese market was controlled by domestic companies, 31.2% by foreign counterparts represented by Johnson & Johnson, Medtronic, Boston Scientific, Abbott, B. Braun and Terumo, and 15.4% by those invested by Hong Kong, Macao and Taiwan. Interventional cardiovascular devices in China include cardiovascular stent, catheter, guidewire, balloon, surgical auxiliary devices, etc., among which cardiovascular stent is predominant. View Complete Report @ http://www.chinamarketresearchreports.com/114928.html .

priyalclinton
Télécharger la présentation

China Interventional Cardiovascular Device Industry 2017

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. China Interventional Cardiovascular Device Industry Report, 2014-2017byResearch in China Published: September 2014 No of Pages: 112 Single User PDF: US$ 2200 Corporate User PDF: US$ 3500 View Complete Report @ http://www.chinamarketresearchreports.com/114928.html

  2. China Interventional Cardiovascular Device Industry Report, 2014-2017 The prevalence of cardiovascular disease in China impacted by accelerated aging of population and changes in consumption concept, dietary habit, way of working and other lifestyles has been growing year after year, thereby promoting the development of domestic percutaneous coronary intervention (PCI) market. PCI cases in China totaled 454,505 in 2013, up 16.9% from a year earlier; meanwhile the interventional cardiovascular device industry there was worth RMB20.12 billion. At present, half of the Chinese interventional cardiovascular device industry is dominated by domestic companies led by MicroPort, Lepu Medical, Lifetech Scientific, and Dalian Yinyi. In 2013, 53.4% of the Chinese market was controlled by domestic companies, 31.2% by foreign counterparts represented by Johnson & Johnson, Medtronic, Boston Scientific, Abbott, B. Braun and Terumo, and 15.4% by those invested by Hong Kong, Macao and Taiwan. Buy a Copy of this Report @ http://www.chinamarketresearchreports.com/contacts/purchase.php?name=114928 .

  3. China Interventional Cardiovascular Device Industry Report, 2014-2017 Cardiovascular stent: In 2013, the Chinese cardiovascular stent market equaled RMB11.2 billion, 78.8% of which was occupied by domestic drug-eluting stents. That same year, 686,000 units of cardiovascular stent were consumed in China, up 11.7% year on year, and drug-eluting stents accounted for 99.5%, indicating that the drug-eluting stent is gradually becoming an important device for interventional cardiovascular therapy. In addition, Abbott has developed biodegradable stents, which are sold in Europe; Lepu Medical is endeavoring to develop biodegradable stents, which are expected to be available on the market in 2017. Thanks to its excellent performance, biodegradable stents are likely to replace drug-eluting stents gradually in the future, thus becoming the main variety in domestic coronary stent market. Inquire for a Discount on this Report @ http://www.chinamarketresearchreports.com/contacts/inquiry.php?name=114928 .

  4. China Interventional Cardiovascular Device Industry Report, 2014-2017 Table of Contents 5. Foreign Companies in China5.1 Johnson & Johnson5.2 Medtronic5.3 Boston Scientific5.4 Abbott Laboratories 6. Major Domestic Companies6.1 MicroPort6.2 Lepu Medical6.3 Lifetech Scientific6.4 JW Medical6.5 Dalian Yinyi Inquire Before Buying @http://www.chinamarketresearchreports.com/contacts/inquire-before-buy.php?name=114928 .

  5. China Interventional Cardiovascular Device Industry Report, 2014-2017 Related Released Market Reports of Research in China Global and China LED Industry Report, 2013-2014 LED saw a turning point in 2013 when Die (L0) and Package (L1) LED market size hit about USD15.188 billion, a rise of 8.3% from 2012. In 2014, the LED market will continue to recover with the market size of USD16.562 billion (up 9.0% from 2013). China Jewelry Industry Report, 2013-2016 In 2013, the global jewelry sales achieved USD184 billion, representing a year-on-year jump of 26.03% , accounting for 57.86% of the global luxury goods sales. In 2013, the jewelry sales in Chinese Mainland approximated USD75.8 billion (USD1= RMB6.2), equivalent to 41.2 % of the global consumption. Browse Life Sciences Reports @http://www.chinamarketresearchreports.com/cat/life-sciences.html .

  6. About us China Market Research Reports is a database of selected syndicated market reports for global and China industries including but not limited to life sciences, information technology & telecommunications, consumer goods, food and beverages, energy and power, automotive and transportation, manufacturing and construction, materials and chemicals, public sector as well as business and financial services.We provide 24/7 online and offline support to our customers.Website : www.chinamarketresearchreports.com Browse Latest Industry News, Updates, Trends, Opportunities, Scenario all over the world @ Call Now + 1 888 391 5441 | Email @sales@chinamarketresearchreports.com

More Related